150 related articles for article (PubMed ID: 36437414)
1. Differential HLA class I subunit (A, B, C heavy chain and β
Ugolini F; Szumera-Ciećkiewicz A; Baroni G; Nesi G; Mandalà M; Ferrone S; Massi D
Virchows Arch; 2023 Feb; 482(2):359-368. PubMed ID: 36437414
[TBL] [Abstract][Full Text] [Related]
2. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors.
Patel SS; Nota SP; Sabbatino F; Nielsen GP; Deshpande V; Wang X; Ferrone S; Schwab JH
Clin Orthop Relat Res; 2021 Jun; 479(6):1373-1382. PubMed ID: 33273248
[TBL] [Abstract][Full Text] [Related]
3. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
Ryu KS; Lee YS; Kim BK; Park YG; Kim YW; Hur SY; Kim TE; Kim IK; Kim JW
Exp Mol Med; 2001 Sep; 33(3):136-44. PubMed ID: 11642549
[TBL] [Abstract][Full Text] [Related]
4. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
5. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.
Temponi M; Kekish U; Hamby CV; Nielsen H; Marboe CC; Ferrone S
J Immunol Methods; 1993 May; 161(2):239-56. PubMed ID: 8505553
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a monoclonal anti-pan HLA class I antibody suitable for immunostaining of formalin-fixed tissue: unusually high frequency of down-regulation in breast cancer tissues.
Torigoe T; Asanuma H; Nakazawa E; Tamura Y; Hirohashi Y; Yamamoto E; Kanaseki T; Hasegawa T; Sato N
Pathol Int; 2012 May; 62(5):303-8. PubMed ID: 22524657
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients.
Tanaka K; Tsuchikawa T; Miyamoto M; Maki T; Ichinokawa M; Kubota KC; Shichinohe T; Hirano S; Ferrone S; Dosaka-Akita H; Matsuno Y; Kondo S
Int J Oncol; 2012 Apr; 40(4):965-74. PubMed ID: 22134332
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte class I antigen and beta2-microglobulin expression in conjunctival dysplasia, carcinoma in situ, and squamous cell carcinoma.
Krishnakumar S; Lakshmi SA; Pusphparaj V; Iyer A; Abhyankar D; Biswas J
Cornea; 2005 Apr; 24(3):337-41. PubMed ID: 15778609
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to HLA-E bind epitopes carried by unfolded β2 m-free heavy chains.
Tremante E; Lo Monaco E; Ingegnere T; Sampaoli C; Fraioli R; Giacomini P
Eur J Immunol; 2015 Aug; 45(8):2356-64. PubMed ID: 25982269
[TBL] [Abstract][Full Text] [Related]
10. Alterations of HLA class I and class II antigen expressions in borderline, invasive and metastatic ovarian cancers.
Le YS; Kim TE; Kim BK; Park YG; Kim GM; Jee SB; Ryu KS; Kim IK; Kim JW
Exp Mol Med; 2002 Mar; 34(1):18-26. PubMed ID: 11989974
[TBL] [Abstract][Full Text] [Related]
11. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
[TBL] [Abstract][Full Text] [Related]
12. Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains.
Desai SA; Wang X; Noronha EJ; Zhou Q; Rebmann V; Grosse-Wilde H; Moy FJ; Powers R; Ferrone S
J Immunol; 2000 Sep; 165(6):3275-83. PubMed ID: 10975844
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer progression may involve a shift in HLA-E profile from an intact heterodimer to β2-microglobulin-free monomer.
Sasaki T; Ravindranath MH; Terasaki PI; Freitas MC; Kawakita S; Jucaud V
Int J Cancer; 2014 Apr; 134(7):1558-70. PubMed ID: 24105714
[TBL] [Abstract][Full Text] [Related]
14. Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens.
Puppo F; Brenci S; Contini P; Bignardi D; Hamby CV; Filaci G; Ghio M; Scudeletti M; Picciotto A; Indiveri F; Ferrone S
Tissue Antigens; 2000 Apr; 55(4):333-41. PubMed ID: 10852385
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
Wang Z; Hu XZ; Tatake RJ; Yang SY; Zeff RA; Ferrone S
Cancer Res; 1993 Sep; 53(18):4303-9. PubMed ID: 7689931
[TBL] [Abstract][Full Text] [Related]
16. Beta2-micro-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with beta2-micro-associated HLA class I heavy chain levels and HLA phenotype.
Puppo F; Bignardi D; Contini P; Hamby CV; Brenci S; Lanza L; Ghio M; Scudeletti M; Indiveri F; Ferrone S
Tissue Antigens; 1999 Mar; 53(3):253-62. PubMed ID: 10203018
[TBL] [Abstract][Full Text] [Related]
17. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules.
Menier C; Saez B; Horejsi V; Martinozzi S; Krawice-Radanne I; Bruel S; Le Danff C; Reboul M; Hilgert I; Rabreau M; Larrad ML; Pla M; Carosella ED; Rouas-Freiss N
Hum Immunol; 2003 Mar; 64(3):315-26. PubMed ID: 12590976
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
[TBL] [Abstract][Full Text] [Related]
19. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
Wang Z; Arienti F; Parmiani G; Ferrone S
Eur J Immunol; 1998 Sep; 28(9):2817-26. PubMed ID: 9754569
[TBL] [Abstract][Full Text] [Related]
20. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
